• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

测量血液中西咪替丁水平有用吗?

Is the measurement of blood cimetidine levels useful?

作者信息

Festen H P, Diemel J, Lamers C B, van Schaik A, Tangerman A, van Tongeren J H

出版信息

Br J Clin Pharmacol. 1981 Sep;12(3):417-21. doi: 10.1111/j.1365-2125.1981.tb01237.x.

DOI:10.1111/j.1365-2125.1981.tb01237.x
PMID:7295472
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1401794/
Abstract

1 Blood cimetidine levels were measured up to 5 h after oral intake of 200 mg cimetidine with breakfast in 13 duodenal, 5 gastric and 15 anastomotic ulcer patients. 2 There were larger inter individual differences in results. The mean peak blood concentrations was 1.14 +/- 0.07 microgram/ml (range 0.54-1.94 microgram/ml), the mean period during which the blood concentration exceeded 0.5 microgram/ml was 141 +/- 11 min (range 23-306 min) and the mean area under the cimetidine blood concentration curve (AUC) was 166 +/- 8 microgram ml-1 min (range 96-280 microgram ml-1 min). Coefficient of variation of these parameters was 33%, 43% and 29% respectively. 3 There were no significant differences in these parameters between non-operated patients and patients with a partial gastrectomy. 4 In 11 patients restudied after 2 to 5 months blood cimetidine levels proved well reproducible; mean coefficient of variation of peak blood levels was 8.5 +/- 2.4%, of time during which blood levels exceeded 0.5 microgram/ml 7.6 +/- 2.5% and of the AUC 5.0 +/- 1.0%. 5 There was no difference in peak blood levels, duration of blood level exceeding 0.5 microgram/ml and blood cimetidine AUC between 24 patients healed after 4 weeks cimetidine therapy and 9 in whom healing took longer. Likewise, there was no evidence of lower blood cimetidine concentrations in 9 patients who relapsed during maintenance cimetidine treatment compared with 24 who did not relapse.

摘要
  1. 在13例十二指肠溃疡患者、5例胃溃疡患者和15例吻合口溃疡患者中,于早餐时口服200毫克西咪替丁后,测定长达5小时的血中西咪替丁水平。2. 结果存在较大的个体差异。血药浓度峰值平均为1.14±0.07微克/毫升(范围0.54 - 1.94微克/毫升),血药浓度超过0.5微克/毫升的平均时长为141±11分钟(范围23 - 306分钟),西咪替丁血药浓度曲线下平均面积(AUC)为166±8微克·毫升⁻¹·分钟(范围96 - 280微克·毫升⁻¹·分钟)。这些参数的变异系数分别为33%、43%和29%。3. 未手术患者和部分胃切除患者在这些参数上无显著差异。4. 在11例患者于2至5个月后重新研究时,血中西咪替丁水平显示出良好的可重复性;血药浓度峰值的平均变异系数为8.5±2.4%,血药浓度超过0.5微克/毫升的时长的平均变异系数为7.6±2.5%,AUC的平均变异系数为5.0±1.0%。5. 接受4周西咪替丁治疗后愈合的24例患者与愈合时间较长的9例患者相比,血药浓度峰值、血药浓度超过0.5微克/毫升的持续时间以及血中西咪替丁AUC无差异。同样,在维持西咪替丁治疗期间复发的9例患者与未复发的24例患者相比,没有证据表明前者血中西咪替丁浓度较低。

相似文献

1
Is the measurement of blood cimetidine levels useful?测量血液中西咪替丁水平有用吗?
Br J Clin Pharmacol. 1981 Sep;12(3):417-21. doi: 10.1111/j.1365-2125.1981.tb01237.x.
2
[Bioavailability of cimetidine after partial gastrectomy (author's transl)].胃部分切除术后西咪替丁的生物利用度(作者译)
MMW Munch Med Wochenschr. 1980 Sep 26;122(39):1337-40.
3
Cimetidine in anastomotic ulceration after partial gastrectomy.西咪替丁与胃部分切除术后吻合口溃疡
Gastroenterology. 1979 Jul;77(1):83-5.
4
The absorption of cimetidine before and during maintenance treatment with cimetidine and the influence of a meal on the absorption of cimetidine--studies in patients with peptic ulcer disease.西咪替丁维持治疗前后的吸收情况以及进餐对西咪替丁吸收的影响——对消化性溃疡病患者的研究
Br J Clin Pharmacol. 1979 Jan;7(1):23-31. doi: 10.1111/j.1365-2125.1979.tb00892.x.
5
Intragastric nitrites, nitrosamines, and bacterial overgrowth during cimetidine treatment.西咪替丁治疗期间胃内亚硝酸盐、亚硝胺及细菌过度生长情况。
Gut. 1982 Dec;23(12):1048-54. doi: 10.1136/gut.23.12.1048.
6
Pharmacokinetic study of cimetidine in pediatric duodenal ulcer.西咪替丁在小儿十二指肠溃疡中的药代动力学研究。
Clin Ther. 1991 Jan-Feb;13(1):118-25.
7
Clinical and pharmacological effectiveness of cimetidine in duodenal ulcer patients.西咪替丁在十二指肠溃疡患者中的临床及药理疗效。
Scand J Gastroenterol. 1979;14(4):489-92.
8
Pharmacokinetics of cimetidine after single doses and during continuous treatment.西咪替丁单次给药及持续治疗期间的药代动力学。
Clin Pharmacokinet. 1981 Jul-Aug;6(4):306-15. doi: 10.2165/00003088-198106040-00005.
9
[Cimetidine treatment of anastomotic ulcers (author's transl)].西咪替丁治疗吻合口溃疡(作者译)
Nouv Presse Med. 1980 Nov 15;9(43):3241-3.
10
[Cimetidine in the treatment of postoperative peptic ulcer].西咪替丁治疗术后消化性溃疡
Arq Gastroenterol. 1982 Apr-Jun;19(2):59-63.

引用本文的文献

1
Refractory duodenal ulcer.难治性十二指肠溃疡
Gut. 1984 Jul;25(7):711-7. doi: 10.1136/gut.25.7.711.
2
Clinical pharmacokinetics of cimetidine.西咪替丁的临床药代动力学
Clin Pharmacokinet. 1983 Nov-Dec;8(6):463-95. doi: 10.2165/00003088-198308060-00001.
3
Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases.雷尼替丁:其药理学及在消化性溃疡疾病和其他相关疾病中的治疗应用综述
Drugs. 1982 Oct;24(4):267-303. doi: 10.2165/00003495-198224040-00002.
4
Factors predicting the therapeutic outcome of duodenal ulcer treatment with H2-receptor antagonists.预测十二指肠溃疡采用H2受体拮抗剂治疗疗效的因素。
Klin Wochenschr. 1985 Nov 15;63(22):1152-9. doi: 10.1007/BF01740590.
5
Famotidine. Pharmacodynamic and pharmacokinetic properties and a preliminary review of its therapeutic use in peptic ulcer disease and Zollinger-Ellison syndrome.法莫替丁。药效学和药代动力学特性及其在消化性溃疡疾病和佐林格-埃利森综合征治疗应用的初步综述。
Drugs. 1986 Sep;32(3):197-221. doi: 10.2165/00003495-198632030-00001.
6
Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).用于治疗胃肠道疾病的药物的临床药代动力学(第二部分)。
Clin Pharmacokinet. 1990 Aug;19(2):94-125. doi: 10.2165/00003088-199019020-00002.

本文引用的文献

1
Pharmacokinetics and bioavailability of cimetidine in gastric and duodenal ulcer patients.西咪替丁在胃溃疡和十二指肠溃疡患者中的药代动力学及生物利用度
Clin Pharmacokinet. 1980 Jan-Feb;5(1):84-94. doi: 10.2165/00003088-198005010-00003.
2
The absorption of cimetidine before and during maintenance treatment with cimetidine and the influence of a meal on the absorption of cimetidine--studies in patients with peptic ulcer disease.西咪替丁维持治疗前后的吸收情况以及进餐对西咪替丁吸收的影响——对消化性溃疡病患者的研究
Br J Clin Pharmacol. 1979 Jan;7(1):23-31. doi: 10.1111/j.1365-2125.1979.tb00892.x.
3
Bioavailability and pharmacokinetics of cimetidine.西咪替丁的生物利用度和药代动力学。
Eur J Clin Pharmacol. 1979 Nov;16(5):335-40. doi: 10.1007/BF00605632.
4
Clinical and pharmacological effectiveness of cimetidine in duodenal ulcer patients.西咪替丁在十二指肠溃疡患者中的临床及药理疗效。
Scand J Gastroenterol. 1979;14(4):489-92.
5
Blood level of cimetidine in relation to age.西咪替丁血药浓度与年龄的关系。
Eur J Clin Pharmacol. 1979 May 21;15(4):257-61. doi: 10.1007/BF00618514.
6
Cimetidine in anastomotic ulceration after partial gastrectomy.西咪替丁与胃部分切除术后吻合口溃疡
Gastroenterology. 1979 Jul;77(1):83-5.
7
Cimetidine: an advance in gastric ulcer treatment?西咪替丁:胃溃疡治疗的一项进展?
Br Med J. 1978 Nov 11;2(6148):1323-6. doi: 10.1136/bmj.2.6148.1323.
8
[Suppression of gastric acid production using cimetidine; results of a double-blind study of the significance of cimetidine for the treatment of peptic ulcers].[使用西咪替丁抑制胃酸分泌;西咪替丁治疗消化性溃疡意义的双盲研究结果]
Ned Tijdschr Geneeskd. 1978 Jun 17;122(24):862-5.
9
Cimetidine treatment of duodenal ulceration: short term clinical trial and maintenance study.西咪替丁治疗十二指肠溃疡:短期临床试验与维持性研究。
Gastroenterology. 1978 Feb;74(2 Pt 2):389-92.
10
Inhibition of gastric acid secretion by cimetidine in patients with duodenal ulcer.西咪替丁对十二指肠溃疡患者胃酸分泌的抑制作用。
N Engl J Med. 1975 Aug 21;293(8):371-5. doi: 10.1056/NEJM197508212930802.